Adelman Daniel C Md - Net Worth and Insider Trading
Adelman Daniel C Md Net Worth
The estimated net worth of Adelman Daniel C Md is at least $732,913 dollars as of 2024-11-05. Adelman Daniel C Md is the Chief Medical Officer of Aimmune Therapeutics Inc and owns about 21,250 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $732,913. Details can be seen in Adelman Daniel C Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adelman Daniel C Md has not made any transactions after 2020-01-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adelman Daniel C Md
Adelman Daniel C Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adelman Daniel C Md owns 3 companies in total, including Aimmune Therapeutics Inc (AIMT) , Sunesis Pharmaceuticals Inc (SNSS) , and Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Adelman Daniel C Md’s form 4 insider trades.
Insider Ownership Summary of Adelman Daniel C Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-10 | Chief Medical Officer |
| SNSS | Sunesis Pharmaceuticals Inc | 2007-09-13 | Sr. VP & Development and CMO |
| VIRX | Viracta Therapeutics Inc | 2005-09-27 | Senior VP,Drug Discovery & Dev |
Adelman Daniel C Md Latest Holdings Summary
Adelman Daniel C Md currently owns a total of 1 stock. Adelman Daniel C Md owns 21,250 shares of Aimmune Therapeutics Inc (AIMT) as of January 2, 2020, with a value of $732,913.
Latest Holdings of Adelman Daniel C Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-01-02 | 21,250 | 34.49 | 732,913 |
Holding Weightings of Adelman Daniel C Md
Adelman Daniel C Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Adelman Daniel C Md has made a total of 2 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aimmune Therapeutics Inc is the sale of 20,000 shares on January 2, 2020, which brought Adelman Daniel C Md around $700,000.
Insider Trading History of Adelman Daniel C Md
- 1
Adelman Daniel C Md Trading Performance
Adelman Daniel C Md Ownership Network
Ownership Network List of Adelman Daniel C Md
Ownership Network Relation of Adelman Daniel C Md
Adelman Daniel C Md Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Adelman Daniel C Md is the Chief Medical Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and See Remarks Douglas T. Sheehy .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Adelman Daniel C Md Mailing Address
Above is the net worth, insider trading, and ownership report for Adelman Daniel C Md. You might contact Adelman Daniel C Md via mailing address: 23 Woodleaf Avenue, Redwood City Ca 94061.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
